Background. Human African trypanosomiasis, caused by Trypanosoma brucei, involves an early hemolymphatic stage followed by a late encephalitic stage.
volved in a number of immune processes, including regulation of lymphocyte differentiation and immune surveillance, by controlling the migration of cells into and from secondary lymphoid organs [8] .
Individual chemokines play opposing roles in neuroinflammation in different experimental models of infectious disease, making it difficult to predict whether chemokines are protective by contributing to immune eradication of the microbial attack or are causing inflammatory damage and disease [9] . Inflammatory chemokines are induced by infection either directly after innate immune receptor recognition of microbial molecules or indirectly via cytokines secreted in response to infection. Among these cytokines, we have previously described a major role for interferon (IFN)-g in the neuropathogenesis of experimental African trypanosomiasis. IFN-g controls parasitemia but paradoxically facilitates the penetration of T cells across the blood-brain barrier into the brain [6] .
Although an association between levels of a few selected chemokines in the CSF and severity of disease in HAT has been described [10, 11] , a systematic analysis of chemokine and chemokine receptor expression during trypanosome infections has not been performed. In this study, we have performed a systematic comparison of the expression of chemokines and chemokine receptors in brains from mice before and after parasite passage across the blood-brain barrier and investigated the role played by chemokines during the encephalitic phase of African trypanosomiasis by using relevant knockout mice.
Our results show that CXCL10 is a highly up-regulated chemokine in astrocytes in mice brains after parasite passage across the blood-brain barrier, is induced by IFN-g and IFN-a/b, facilitates parasite and T cell accumulation in the brain, and accounts at least in part for morbidity. Furthermore, elevated levels of CXCL10 are detected in the CSF of patients with late stage HAT and are associated with low body weight, somnolence, and the presence of trypanosomes within the CSF. We thereby identified CXCL10 as a main regulator in the pathogenesis of African trypanosomiasis as well as a candidate marker of late stage disease.
MATERIALS AND METHODS

Patients and specimens.
Patients with early and late stage HAT were recruited from the area around Dipumba Hospital, Mbuji Mayi, Democratic Republic of Congo, where sleeping sickness due to Trypanosoma brucei gambiense is endemic. Persons who were seropositive in the card agglutination test for Trypanosomiasis [12] or who presented with suggestive clinical signs were examined for trypanosomes in the blood by capillary tube centrifugation or mini anion exchange centrifugation technique in lymph node aspirate by direct examination and in CSF specimens by modified single centrifugation [13] . The late stage disease was defined as either white blood cell count 15 cells/mL in CSF specimens, counted in disposable counting chambers, or detection of trypanosomes in CSF specimens. The study protocol was approved by the Ministry of Health, Kinshasa, Democratic Republic of Congo, and the Ethical Committee of the University Hospital of Antwerp, Belgium. Patients who were aged !12 years, were moribund, or had "bloodcontaminated" CSF were excluded from this study. Somnolence, as determined by the clinician, was defined with sleepiness rating of у5 on the Stanford Sleepiness Scale.
Mice, parasites, and infection. Mice deficient in IFN-g [14] , IFN-a/b receptor [15] , CXCR3 [16] , or CXCL10 [17] were generated by homologous recombination in embryonic stem cells. All strains were back-crossed to a C57BL/6 background, and C57BL/6 mice were used as controls. All experiments were authorized by the local animal research ethical committee. Mice (aged 8-12 weeks; 8-10 mice per group), were infected intraperitoneally with to parasites of a Complementary DNA (cDNA) microarray analysis. A transcriptome analysis of total RNA obtained from brains of mice sacrificed before or after parasite penetration into the brain parenchyma was performed as described elsewhere [18] .
Real-time reverse-transcriptase polymerase chain reaction (RT-PCR). Gene transcripts of several chemokines were quantified in brains from wild-type, IFN-g Ϫ/Ϫ , IFN-a/b receptor Ϫ/Ϫ and CXCL10 Ϫ/Ϫ uninfected and infected mice by realtime RT-PCR as described elsewhere [7] . The following primers were used: cyclophilin, sequence described elsewhere [7] ; sense CCL5, 5'-CTCGGTCCTGGGAAAATGG-3'; antisense CCL5, 5'-TGCTGATTTCTTGGGTTTGCT-3'; sense CCL28, 5'-GAA-GCGCATGGAGCTCTGA-3'; antisense CCL28, 5'-AGCTAGG-TGGATCTCTGTGAGTTTG-3'; sense CXCL9, 5'-GCCATGA-AGTCCGCTGTTCT-3'; antisense CXCL9, 5'-GGGTTCCT-CGAACTCCACACT-3'; sense CXCL10, 5'-GACGGTCCGCT-GCAACTG-3'; antisense CXCL10 5'-GCTTCCCTATGGCCC-TCATT-3'; sense CXCL11, 5'-GCCCTGGCTGCGATCAT-3'; and antisense CXCL11, 5'-ACAGCGCCCCTGTTTGAA-3'. Immunohistochemical techniques. To examine passage of trypanosomes across the blood-brain barrier, sections of nonperfused, fresh, frozen brains at a level of the lateral ventricles containing the choroid plexus and septal nuclei were cut, mounted, fixed, and immunostained with either anti-AnTat 1.1 VSG, anti-CD4, or anti-CD8 to determine parasites or T cell presence together with anti-glucose transporter 1 labeling brain endothelial cells as described elsewhere [6] . Microglia and astrocytes were visualized by labeling with anti-Iba1 and anti-GFAP antibodies respectively. The CXCL10 double immunofluorescence staining with GFAP, IbaI, CD4, and CD3 was performed as described elsewhere [19] . Some of the sections were counterstained with DAPI nuclear staining. To determine whether there was neurodegeneration in infected mice, brain sections were stained with b-amyloid precursor protein as described elsewhere [20] .
In situ hybridization. The in situ hybridization technique to detect CXCL10 messenger RNA (mRNA) accumulation in the brains of T. brucei-infected mice was performed as described elsewhere [19] .
Measurement of cytokines/chemokines in CSF of patients with HAT. The levels of IFN-g and CXCL10 were determined in CSF samples of 20 patients with stage 1 HAT, 20 patients with stage II HAT, and 20 uninfected individuals. The concentration of CXCL10 was determined using a Quantikine human CXCL10 kit (R&D Systems) with a detection limit of 8 pg/mL. IFN-g levels were measured using a solid phase sandwich enzyme-linked immunosorbent assay (ELISA) (OptiEIA; BDPharmingen) with a detection limit of 5 pg/mL.
RESULTS
Identification and regulation of chemokine mRNA levels in the brain of T. brucei brucei-infected mice. To define which chemokines are differentially expressed during the encephalitic phase of experimental African trypanosomiasis, we compared transcript levels in brain tissues of T. brucei brucei-infected mice harvested at 3 different times after infection with use of a high density microarray. Trypanosomes are located within the hemolymphatic system at 6 days after infection; at 15 days after infection, few parasites have penetrated into the brain parenchyma, whereas numerous trypanosomes are present in the brain parenchyma at 28 days after infection. The levels of several chemokine and chemokine receptor transcripts were higher at 28 days than at 6 days after infection (Table 1) . Among these, CXCL10, CXCL9, CXCL13, and CCL5 and CCL28 mRNA showed the highest increase ratio. The enhanced expression of chemokine transcripts in infected wild-type mice was confirmed by real-time RT-PCR for all chemokines except CCL28 ( Figure 1A) .
IFN-g and IFN-a/b have been reported to regulate the expression of CXCL9 and CXCL10 [21] [22] [23] . In line with this, CXCL9 and CXCL10 mRNA levels were reduced in brains of IFN-g Ϫ/Ϫ infected mice, compared with wild-type infected control mice, at 20 days after infection ( Figure 1A ). On the other hand, CXCL10 but not CXCL9 mRNA levels were slightly reduced in brains of infected IFN-a/b receptor Ϫ/Ϫ mice, compared with wild-type mice, at 30 days after infection ( Figure 1B ). Topological and cellular localization of CXCL10 expression. First, we performed in situ hybridization on mice brain sections to investigate whether CXCL10 mRNA expression varied during the course of T. brucei brucei infection. Interestingly, there was a progressive increase in CXCL10 mRNA levels in the brains of infected mice at 6 ( ), 15 ( ), and 28 ( ) days n p 4 n p 3 n p 3 after infection ( Figure 2B-2G ), but CXCL10 mRNA was absent in brains of uninfected mice ( ; Figure 2A) . Although the n p 4 CXCL10 mRNA was expressed mainly in blood vessel-associated cells at 6 days after infection ( Figure 2B) , most of the vessel-associated CXCL10 mRNA-positive cells had disappeared, and instead, clusters of mRNA-positive glial-like cells expressing high levels of CXCL10 became visible in the brain parenchyma at 15 days after infection ( Figure 2C ). Clusters were specially observed in the hypothalamus, the optic chiasm, and the optic tracts. At 28 days after infection, clusters of CXCL10 mRNA-positive cells with distinct glial morphology were widely distributed in both hemispheres, including the septal nuclei, caudate putamen, corpus callosum, and cerebral cortex ( Figure 2D ). The CXCL10 mRNA-positive cells appeared to be more evenly distributed within the corpus callosum, optic chiasm, and optic tracts, compared with cells in the grey matter. Ependymal and meningeal cells contained increasing levels of CXCL10 mRNA as infection progressed ( Figure 2E and 2F) .
Next, the identity of the CXCL10 mRNA-positive cells (Figure 3A) was determined by combining in situ hybridization with immunohistochemistry. CXCL10 mRNA staining was localized in GFAP-negative cells within the blood vessels at 6 days after infection (data not shown) and was colocalized with GFAP-positive astrocytes at 15 and 28 days after infection (Figure 3B) . Few CXCL10-positive cells were detected at 6 days after infection by labeling with anti-chemokine antibodies (data not shown). In agreement with observations made in CXCL10 mRNA-positive cells, increasing numbers of CXCL10-positive cells were noted in clusters at 15 and 28 days after infection. CXCL10 protein was localized in GFAP-positive astrocytes (Figure 3C ) but was not found in Iba1-positive microglia ( Figure  3D ) or in CD4 + and CD3 + T cells ( Figure 3E and 3F). At 28 days after infection, the CXCL10-positive astrocytes were localized in inflammatory foci containing Iba1-positive microglia and CD3 + and CD4 + T cells ( Figure 3D-3F ). This observation was based on assessment of 4-8 sections from 3 mice per investigated time point.
Role of CXCR3 and CCL10 in the outcome of T. brucei brucei infection. IFN-g increases neuroinvasion of trypanosomes and T cells [6] . Because IFN-g-inducible CXCL10 mRNA levels were increased during the late stage of T. brucei brucei infection, the role of CXCL10 and its receptor CXCR3 [24, 25] in the outcome of the infection was investigated. Whereas wild-type mice inoculated with T. brucei brucei showed significant loss of weight, infected CXCL10 Ϫ/Ϫ and CXCR3
Ϫ/Ϫ mice showed no weight loss during the observation period ( Figure 4A ). Similar parasitemia levels were registered in mutant and wild-type mice ( Figure 4B ). Next, we studied whether the reduced morbidity observed Because CXCR3 is also the receptor for CXCL9 [25] , we studied whether the absence of CXCL10 affected the levels of Increased levels of CXCL10 were associated with increased somnolence, decreased body weight and higher number of trypanosomes in the CSF, but not in the blood, within the late stage patients (Figure 6C-6F) . The concentration of CXCL10 in patients with late-stage infection was not related to age or sex.
DISCUSSION
This study shows that CXCL10 plays an important role in enhancing neuroinflammation in T. brucei brucei-infected mice and proposes that CXCL10 could be considered to be a candidate marker for late-stage HAT. Together with CXCL10, CXCL9 and CXCL11 bind to CXCR3, which is expressed on activated T cells, Natural Killer cells, and monocytes/macrophages [25, 26] . CD8 + T cell levels are reduced in brains of lymphocytic choriomeningitis virus (LCMV)-infected CXCL10 Ϫ/Ϫ and CXCR3 Ϫ/Ϫ mice [27, 28] , and CD4+ T cell levels are reduced in brains of mouse hepatitis virus-infected mice treated with anti-CXCR3 antibodies [29] ; we observed a reduction of both T cells populations in the brains of trypanosome-infected CXCL10 Ϫ/Ϫ and CXCR3 Ϫ/Ϫ mice, compared with wild-type mice. CXCL9 and CXCL10 gene transcripts are strongly expressed in a mouse model of cerebral malaria, and CXCR3 Ϫ/Ϫ malariainfected mice have reduced numbers of CD8 + T cells in the brain [30, 31] . Similar to LCMV and malaria infections, morbidity was reduced among T. brucei brucei-infected CXCL10 Ϫ/Ϫ and CXCR3 Ϫ/Ϫ mice. However, striking differences in the distribution of the T cells in the brain during T. brucei brucei, LCMV, and Plasmodium falciparum infections can be noted despite the fact that CXCL10 is strongly up-regulated in all 3 disease models. Whereas widely scattered CD4 + and CD8 + T cells predominate in hypothalamic areas, septal nuclei, and white matter in T. brucei brucei-infected mice, CD8 + T cells are observed around the surfaces of the ventricular system as well as in the major white matter tracts in LCMV-infected mice. In P. falciparum-infected mice, CD8 + T cells are, on the other hand, sequestered within cerebral vessels in various brain regions and do not infiltrate the parenchyma. The T cells in these 3 different infections, therefore, demonstrate a topological localization in the brain that is similar to that of the pathogens.
The spatial-temporal expression profile of CXCL10 seemed to mirror the course of the trypanosome infection in the brain.
During the hemolymphatic stage of the disease, 6 days after infection in our mouse model, CXCL10 was found in cells of the choroid plexus and in cells associated with cerebral blood vessels with a widespread distribution in the brain. However, later during the course of the disease, when trypanosomes were observed in brain parenchyma in addition to the choroid plexus, CXCL10 expression was up-regulated not only in meningeal and ependymal cells but also in astrocytes, which appeared to cluster around vessels in regions of the brain showing T cell infiltration. Astrocyte activation has previously been implicated in the pathobiology of African trypanosomiasis [32, 33] . In accordance, CXCR3 signaling has been suggested to constrain CD4 + T cells to perivascular spaces in an experimental allergic encephalomyelitis model [34] . Also in such a model, the central nervous system expression of the CXCL10 gene occurred predominantly in parenchymal astrocytes that surrounded inflammatory lesions [35] .
In our African trypanosomiasis disease model, CXCL10 was up-regulated in parenchymal astrocytes of hypothalamic regions, optic chiasm, and optic tracts when trypanosomes [36] and T cells [37] have infiltrated and IL-1, TNF-a, and IFN-g mRNAs have been induced [38] in the nearby circumventricular organs and choroid plexus for an extended period of time. It could therefore be speculated that, over time, cytokines produced in these areas may leak through their surrounding barriers and the choroid plexus epithelia into the CSF to induce CXCL10 production in ependymal and meningeal cells and between ependymal cells into the brain parenchyma [39] , to induce chemokine production in astrocytes as observed by others [40] . The CXCL10 expression in perivascular astrocytes may facilitate the passage of T cells accompanied by the parasites across the blood-brain barrier to these areas of the brain. The infiltrating T cells would then augment the process by secreting IFN-g, which in turn induces more widespread expression of CXCL10 [6] .
We have previously observed that the passage of trypanosomes across the blood-brain barrier, which occurs at a late stage of infection, is a multistep process similar to that of leukocytes [6] . Although the endothelial basement membrane is permissive to parasite penetration, modifications of the astrocytic basement membrane by IFN-g-dependent factors are required to permit trypanosome passage. In the absence of IFNg, trypanosomes are trapped between the basement membranes, forming cuffs [6] . Such cuffing of trypanosomes around vessels was not observed in CXCL10 Ϫ/Ϫ or CXCR3 Ϫ/Ϫ mice, which demonstrates that CXCL10 is not involved in facilitating the passage of trypanosomes across the astrocytic basement membrane but could play a role by increasing the trafficking of both leukocytes and trypanosomes over the cerebral endothelial cells or by increasing their retention in the brain parenchyma. The distribution of inflammatory cells and trypanosomes in CXCR3 Ϫ/Ϫ , CXCL10 Ϫ/Ϫ , and IFN-g Ϫ/Ϫ mice therefore suggests the involvement of different IFN-g-regulated genes in cerebral penetration of leukocytes and parasites. Similar to that observed for LCMV infection [28] and in the experimental allergic encephalomyelitis model [9] , we observed diminished levels of CXCL9 mRNA in brains of T. brucei brucei-infected CXCL10 Ϫ/Ϫ mice. CXCL9 production is induced by IFN-g [23] . The reduction in CXCL9 transcripts observed in T. brucei brucei-infected CXCL10 Ϫ/Ϫ mice, compared with wild-type mice, is therefore most likely attributable to the reduced T cell accumulation in the brain that results in less IFN-g production in knockout mice. CXCL11 is also a high affinity ligand for CXCR3; however, in the C57BL6 mouse strain CXCL11 it is likely nonfunctional as a result of a single point mutation that deletes a nucleotide base within the coding sequence of the CXCL11 gene [35] . Of interest, IFN-a/b also seemed to play a role in the increased CXCL10 but not CXCL9 mRNA levels during the late phase of T. brucei brucei infection. The regulation of CXCL10 by IFN-a/b has been shown in other experimental systems [22] , but the role of IFN-a/b, a family of important immunoregulatory cytokines, has not been studied in detail, particularly during the early stages of infection with T. brucei brucei.
Although drugs for treatment of the early stage of HAT are efficient, many, if not most, patients seek medical advice only when reaching the meningoencephalitic stage, for which toxic arsenic compounds are widely used. Better diagnostic markers are needed to distinguish the 2 stages of infection; presently, this distinction relies on the finding of increased numbers of leukocytes and/or trypanosomes in the CSF and/or detectable levels of intrathecal immunoglobulin M. It has been shown that levels of CXCL8, CCL2, and CCL3 [10, 11] in the CSF associate with disease severity in patients with HAT. Concentrations of IFN-g in CSF and/or plasma of patients with late-stage HAT have also been associated with disease severity [41] . The detection of CXCL10 mRNA in the mouse brain after trypanosomes had crossed the blood-brain barrier suggested that this molecule could also be an interesting candidate to distinguish between the stages before and after parasites have invaded the brain patients with HAT. In fact, high levels of CXCL10 were found in the CSF of patients with late-stage HAT, whereas none of the patients with early-stage HAT demonstrated increased concentrations of the chemokine. Levels of CXCL10 were associated with the degree of somnolence and loss of body weight. The presence of trypanosomes in the CSF but not in blood was also associated with increased levels of CXCL10 in the CSF, altogether suggesting that CXCL10 could be considered to be a new candidate marker to be further evaluated for determining the stage of disease. In line with our results, it has been recently reported that, of 13 cytokines/chemokines screened in the CSF, CXCL10 seemed to best distinguish between early-and latestage HAT [42] .
In conclusion, we identified CXCL10 as an IFN-g-regulated chemokine that is robustly increased at late stages of infection with African trypanosomes in humans and mice. Binding of CXCL10 to CXCR3 facilitates T cell and parasite accumulation in the brain parenchyma during murine trypanosomiasis and plays an important role in the morbidity observed in the late stage of the infection.
